Pfizer

Stories 101 - 120 | << Prev   Next >>

This Long-Awaited Moment Arrives in US

First doses of COVID vaccine are administered

(Newser) - It's a big moment in the COVID fight: The first doses of a vaccine have been administered in the US. "I feel hopeful today. Relieved," ICU nurse Sandra Lindsay tells the AP after getting her shot at Long Island Jewish Medical Center in New York. She was...

First COVID Vaccines Heading to a City Near You (Maybe)

The first shipments of Pfizer’s vaccine will be staggered

(Newser) - The first trucks carrying a COVID-19 vaccine for widespread use in the United States pulled out of a Michigan manufacturing facility Sunday, with the shots that are critical to stopping the nation’s coronavirus outbreak destined to reach states a day later. Per the AP , shipments of the Pfizer vaccine...

Delivery Date Set for COVID Vaccine
Delivery Date Set
for COVID Vaccine

Delivery Date Set for COVID Vaccine

Gen. Gustave Perna says it will arrive Monday

(Newser) - America's first COVID-19 vaccine is scheduled to ship Sunday and begin arriving Monday morning—the result of a historic effort to protect people from a virus that has killed nearly 300,000 in the US and 1.6 million worldwide. "As I speak today, right now, vaccines are...

Trump Aide Threatens FDA to OK Vaccine

Agency chief Stephen Hahn told to resign if it's not done by end of the day

(Newser) - The FDA and Pfizer were scrambling Friday to announce approval of the coronavirus vaccine after a threat from the White House. President Trump's chief of staff told the agency's commissioner to resign if the vaccine isn't cleared by the end of the day, the Washington Post reports....

Teenagers, Allergies Gave FDA Vaccine Panel Pause

Members want more research on groups largely left out of Pfizer trial

(Newser) - After months of scientific discovery and debate, and waiting, the critical moment for FDA advisory panel members arrived about 5:30pm Thursday. The question put to them for an up-or-down vote was: "Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine outweigh...

This Could Be Big Day for Vaccine Approval in US
FDA Panel Approves
Pfizer Vaccine for US
updated

FDA Panel Approves Pfizer Vaccine for US

The agency is to announce its final decision in days

(Newser) - A federal government advisory panel has endorsed Pfizer's coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. The advisory group of outside experts, in...

As UK Begins Shots, Progress on US Front

Pfizer candidate clears hurdle ahead of crucial Thursday meeting

(Newser) - It's a big news day for COVID vaccines on three fronts:
  • The UK began its first vaccinations .
  • In the US, health regulators say in their initial review that Pfizer's vaccine is 95% protective, per the AP . The review posted online Tuesday by the FDA comes before a Thursday
...

Sources: US Didn't Get in Line Fast Enough for More Vaccine

Pfizer promised 100M initial doses to US, but it's reportedly committed additional supply to others

(Newser) - As Pfizer wrangles with supply chain issues for 2020 distribution of the COVID-19 vaccine, some more potential bad news for American patients: The Washington Post and New York Times report the company has told the Trump administration that, after the initial 100 million doses it agreed to deliver by March,...

90-Year-Old Grandmother Gets First UK Vaccine
UK Rolls Out Its Vaccine

UK Rolls Out Its Vaccine

90-year-old grandmother is the first recipient

(Newser) - Margaret Keenan turns 91 next week but already has her gift from the UK government. Keenan was the first person to receive a vaccine dose Tuesday as part of the UK's mass vaccination program , which will be rolling out 800,000 doses of Pfizer and BioNTech's vaccine at...

Pfizer Cuts Expectations in Half
Pfizer Cuts Expectations in Half

Pfizer Cuts Expectations in Half

Company says supply-chain issues will reduce coronavirus vaccine doses shipped this year to 50M

(Newser) - Saying there have been issues in the supply chain, Pfizer has reduced its projections for the number of coronavirus vaccine doses it will ship this year by half. "Scaling up the raw material supply chain took longer than expected," a spokeswoman said. "And it's important to...

Fauci: Britain Was a Little Too Quick With Vaccine

Approval was based on company data and rushed, expert says

(Newser) - We need coronavirus vaccines quickly, but not before their time. Dr. Anthony Fauci was critical Thursday of Britain's quick green light for a vaccine developed by Pfizer and BioNTech, Politico reports. "They really rushed through that approval," Fauci said. Britain became the first Western nation to OK...

With Vaccines on Deck for Distribution, a 'Real Concern'

After seeing numbers, governors worry there aren't enough initial doses

(Newser) - This week, a federal advisory panel recommended health care workers be among the first to get the COVID-19 vaccine when it's authorized for use. And in a document viewed by CBS News , Operation Warp Speed officials say 6.4 million doses of the Pfizer vaccine would be ready to...

First Country Approves Pfizer Vaccine

UK to begin vaccinations 'within days'

(Newser) - British officials authorized a COVID-19 vaccine for emergency use on Wednesday, greenlighting the world's first shot against the virus that's backed by rigorous science and taking a major step toward eventually ending the pandemic. The go-ahead for the vaccine developed by Pfizer and BioNTech comes as the virus...

Third Strong Vaccine May Have Big Advantage

AstraZeneca's candidate is up to 90% effective, and it can be easily stored and shipped

(Newser) - A third COVID vaccine candidate is reporting strong results —and this one would be easier to transport and store than the first two. AstraZeneca says interim results show that its vaccine is up to 90% effective, slightly less than the 95% reported by Pfizer and Moderna . But while its...

Warp Speed Boss Has Target Date for First Shot

Immunizations could begin Dec. 12, Slaoui says

(Newser) - The head of the US effort to produce a coronavirus vaccine says the first immunizations could happen on Dec. 12. A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.'s request for an emergency use authorization for its developing COVID-19 vaccine....

Pfizer Makes Big Move as a Different COVID Record Falls

Number of US hospitalizations exceeds 80K for first time

(Newser) - The next big step toward a COVID vaccine took place on Friday. Pfizer formally sought US regulators' approval of its vaccine, which has shown to be 95% effective in clinical trials, reports the AP and STAT News . FDA scientists are expected to give the green light for distribution in a...

Why Demand for Dry Ice Is Soaring
Why Demand for
Dry Ice Is Soaring

Why Demand for Dry Ice Is Soaring

Pfizer vaccine needs to be store at ultracold temperature

(Newser) - Demand for dry ice is off the charts—and it's not because of a resurgence in heavy metal concerts. Pfizer and BioNTech's coronavirus vaccine, which could receive emergency use authorization from the FDA within days , needs to be stored at -112 degrees Fahrenheit to be effective. That temperature...

Final Analysis of Pfizer's Vaccine Trials Even Better

Final analysis of late-stage trials shows it's 95% effective, with no major safety worries

(Newser) - More good news from Pfizer and BioNTech, its German partner in the race to produce a coronavirus vaccine: They're expecting to seek an emergency use OK from the Food and Drug Administration "within days," per a statement cited by CNN . That's due to a final analysis...

Trump Resurfaces to Tout Vaccine
Trump
Emerges
to Tout
Vaccine
UPDATED

Trump Emerges to Tout Vaccine

Rose Garden comments don't include a concession to Biden

(Newser) - Gliding over significant challenges still to come, President Trump on Friday offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. Trump still did not concede the election, and he did not...

Pfizer CEO Sold Big Chunk of Shares on Day of Vaccine News

He sold $5.6M in shares as price soared

(Newser) - Pfizer CEO Albert Bourla sold a big chunk of his shares on the same day the company announced very promising news on a coronavirus vaccine , according to an SEC filing. Bourla sold shares worth $5.6 million as the company's stock price soared on Monday, but the company says...

Stories 101 - 120 | << Prev   Next >>
Most Read on Newser